<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="180826">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00740701</url>
  </required_header>
  <id_info>
    <org_study_id>G000078</org_study_id>
    <secondary_id>R01MH060234</secondary_id>
    <secondary_id>R01AG021501</secondary_id>
    <nct_id>NCT00740701</nct_id>
  </id_info>
  <brief_title>Effects of Transcranial Magnetic Stimulation to the Cerebellum on Cognition</brief_title>
  <official_title>fMRI and TMS Analysis of Cerebellar Cognitive Function</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>John E. Desmond</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Institute of Mental Health (NIMH)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>National Institute on Aging (NIA)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Johns Hopkins University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Functional neuroimaging studies have shown that the cerebellum is active during cognitive
      performance. The investigators hypothesize that stimulation of the cerebellum with
      transcranial magnetic stimulation will produce brief changes in performance of the task,
      suggesting that cerebellar activation is necessary for normal cognitive function.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>April 2000</start_date>
  <completion_date type="Anticipated">July 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Participant</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Behavioral performance (accuracy, or rate of conditioned responses)</measure>
    <time_frame>during computerized task performance (2 hours)</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Reaction time</measure>
    <time_frame>during performance of computerized task (2 hours)</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">188</enrollment>
  <condition>Cognitive Performance</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Cerebellar transcranial magnetic stimulation</intervention_name>
    <description>single pulse TMS or repetitive TMS at 1 Hz frequency</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  19-30 years of age

          -  Informed consent

        Exclusion Criteria:

          -  History of seizure or a family history of epilepsy

          -  History of stroke

          -  Presence of metal anywhere in the head except the mouth

          -  Presence of cardiac pacemakers

          -  Presence of cochlear implants

          -  Presence of implanted medication pump

          -  History of heart disease

          -  Presence of intracardiac lines

          -  Increased intracranial pressure, such as after infarctions or trauma

          -  Children, or outside of age range

          -  Pregnancy

          -  Currently taking tricyclic anti-depressants or neuroleptic medication

          -  History of head trauma

          -  History of respiratory disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>19 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John E Desmond, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Johns Hopkins University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kennedy Krieger Institute</name>
      <address>
        <city>Baltimore</city>
        <state>Maryland</state>
        <zip>21205</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <lastchanged_date>March 7, 2017</lastchanged_date>
  <firstreceived_date>August 22, 2008</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Johns Hopkins University</investigator_affiliation>
    <investigator_full_name>John E. Desmond</investigator_full_name>
    <investigator_title>Professor of Neurology</investigator_title>
  </responsible_party>
  <keyword>TMS</keyword>
  <keyword>fMRI</keyword>
  <keyword>verbal working memory</keyword>
  <keyword>classical conditioning</keyword>
  <keyword>eyeblink</keyword>
  <keyword>classical eyeblink conditioning</keyword>
  <keyword>Healthy subjects</keyword>
  <keyword>Memory</keyword>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
